Chicago Fed President Austan Goolsbee is still more concerned about the inflation side of the Fed's mandate than he is about the employment side. This is noteworthy because in general markets are expecting rate cuts to come soon, and also Chairman Jerome Powell, speaking in Jackson Hole, put more weight on risks to the labor market.

In this episode recorded at the conference, Goolsbee explains why he has some concerns about whether the inflation embers have been fully stamped out (he's particularly concerned by what he's seeing in the services realm), and why he has relatively more confidence that the labor market is in good shape.

See omnystudio.com/listener for privacy information.

In a speech at the annual Jackson Hole Economic Policy Symposium, Fed Chair Jerome Powell left the door open for a possible interest rate cut in September, sending a positive signal to Wall Street that pushed markets higher.

This comes at a unique moment for the US Central Bank, which is under fire for how its handled rate decisions, threats to fire a sitting governor and a public inquiry into its building renovations.

On today’s Big Take podcast, Bloomberg’s Amara Omeokwe joins host Saleha Mohsin from Jackson Hole to discuss how central bankers and economic policy leaders are navigating the tensions between the White House and the Federal Reserve — and what we learned from Jay Powell’s last speech at Jackson Hole as chairman.

Listen more: Odd Lots: Lots More on What Just Happened With the Fed at Jackson Hole (Podcast)

See omnystudio.com/listener for privacy information.

The Trump Administration wants to “make America healthy again” and one of its top priorities is removing artificial dyes from food. The company behind Welch’s Fruit Snacks has spent the past ten years doing just that.

On today’s Big Take podcast, Bloomberg’s Will Kubzansky takes us inside the Welch’s Fruit Snacks factory and explores the challenges America’s other food and drink companies could face as they try to meet the MAHA moment and make a similar change under a much faster timeline.

Read more: Making Fruit Snacks Without Synthetic Dye

See omnystudio.com/listener for privacy information.

From Starbucks and Intel to Petco and Astronomer: top CEOs are getting replaced at record rates. And the costs of these ousters can spiral quickly, dinging a company’s stock price and costing us all in surprising ways in the process.

On today’s Big Take podcast, Bloomberg’s management and work reporter Matthew Boyle joins host Sarah Holder to dig into the often murky, always steep cost of a CEO ouster.

Read more: The True Cost of Firing a CEO

See omnystudio.com/listener for privacy information.

After meeting with President Trump separately, Presidents Putin and Zelenskiy could be headed toward a pivotal face-to-face meeting to begin peace talks. But what each side is willing to give up to end the Russia-Ukraine war remains to be seen.

On today’s Big Take podcast, David Gura sits down with Bloomberg’s White House correspondent Justin Sink and Europe government editor Piotr Skolimowski to discuss Russia and Ukraine’s red lines and the role the US and Europe could play in guaranteeing a ceasefire.

See omnystudio.com/listener for privacy information.

At this point in the war between Israel and Hamas, it’s difficult to get more than anecdotal evidence out of Gaza. Almost every organization that once provided aid and monitored civilian welfare is no longer allowed in — or has ceased operations. Very few journalists are left there.

But reports of a civilian population facing a hunger crisis are widespread.

To understand the reality on the ground, host David Gura talked to Bloomberg’s Israel bureau chief Ethan Bronner, UN reporter Magdalena Del Valle and Gaza reporter Fares Alghoul to understand how a hunger crisis unfolded there despite months of warnings.

Read more:

How Gaza Descended Into a Hunger Crisis, Explained

Israel Intends to Fully Take Over Gaza Despite Global Isolation

See omnystudio.com/listener for privacy information.

When a shortage of brand-name weight-loss drugs like Ozempic and Wegovy cleared the way for companies like Hims to fill the gap with cheaper, compounded versions, customers came flocking. But in February, the US Food and Drug Administration announced the shortage was over, leaving the company's strategy in flux and some investors worried.

On today’s Big Take podcast, host David Gura and Bloomberg healthcare reporter Madison Muller track how Hims became the king of copycat weight-loss drugs and what’s next for the company as it fights to hold onto the crown.

Read more: How Hims Became the King of Knockoff Weight-Loss Drugs

Cheap Ozempic Knockoffs Are Suddenly Everywhere. Are They Safe?

The Weight-Loss Drug Boom’s Prescription Problem

Listen and follow The Big Take on Apple Podcasts, Spotify or wherever you get your podcasts.

See omnystudio.com/listener for privacy information.

In an unusual deal, Nvidia and Advanced Micro Devices have agreed to pay the US government 15% of their revenue from AI chips they sell to China. The US has blocked the sale of other, more powerful chips to China on the basis of national security, but the exception underscores the Trump administration’s openness to make exceptions… if the price is right.

On today’s Big Take podcast, Bloomberg economic statecraft reporter Joe Deaux joins host Sarah Holder to explain the unprecedented nature of the deal, concerns about its legality and how it fits into Trump’s approach to trade with global competitors.

See omnystudio.com/listener for privacy information.